Canaccord Genuity Maintains Buy on Hinge Health, Raises Price Target to $134
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice Target
Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $105 to $134.
Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $105 to $134.